baber/WOPTO huggingface dataset:
Patent FI-902647-A0 (FI)
Inventor: VOLLMAN NORBERT CHRISTIAN
IPC: G11B23/087
Filed: 1990-05-28
Abstract: A new system for recording/reproducing signals on magnetic tape in cassettes comprises new apparatuses (DR2) and cassettes (C2) in conformity with a new standard which deviates from an existing standard which prescribes apparatuses (DR1) and cassettes (C1). The new cassette (C2) is a modification of the old cassette (C1) and has the same principal dimensions but a deviating exterior shape so that cassettes of both types, although they are substantially similar and has the same principal dimensions, can be distinguished from one another by a user in a distinctly visible and distinctly tactile manner even in the absence of a distinctive labelling.
Patent FI-911131-A0 (FI)
Inventor: WARD SUSAN JEAN
IPC: C07D405/14
Filed: 1991-03-06
Abstract: Antiglaucoma compositions containing 3-arylcarbonyl-1-aminoalkyl-1H-indoles, as the active component thereof, and a method of use thereof in the treatment of glaucoma. Also included are novel 3-arylcarbonyl-1-aminoalkyl-1H-indoles.
Patent FI-911646-A0 (FI)
Inventor: GRIES HEINZ
IPC: A61K49/06
Filed: 1991-04-05
Abstract: Compounds of the general formula I <IMAGE>  in which     Z<1> and Z<2> in each case represent a hydrogen atom or the radical  -(CH2)m-(C6H4)q-(O)k-(CH2)n-(C6H4)<SB >l-(O)r-R,  in which     m and n denote the figures 0-20,   k, l, q and r denote the figures 0 and 1 and R denotes a hydrogen atom, an optionally OR<1>-substituted C1-C6-alkyl radical or a CH2COOR<1> group where R<1> denotes a hydrogen atom, a C1-C6-alkyl radical or a benzyl group,   R<2> represents a saturated, unsaturated, straight- or branched-chain or cyclic alkyl group having up to 20 C atoms, aryl group or aralkyl group substituted by a carboxyl group optionally esterified with a C1-C6-alkyl or benzyl radical, or by a sulphone group, R<3> represents a hydrogen atom or a saturated, unsaturated, straight- or branched-chain or cyclic alkyl group having up to 20 C atoms, aryl group or aralkyl group optionally substituted by a carboxyl group which is optionally esterified with a C1-C6-alkyl or benzyl radical, or by a sulphone group, X represents a hydrogen atom and/or a metal ion equivalent of an element of atomic number 21-29, 31, 32, 37-40, 42-44, 49 or 57-83, with the proviso that at least one of the substituents Z<1> and Z<2> represents a hydrogen atom, that - when n and l each represent the figure 0 - k and r do not simultaneously each denote the figure 1 and that, if desired, the radical of the acid groups is present as an ester or amide, and their salts with inorganic and/or organic bases, amino acids or amino acid amides, are useful pharmaceutical agents.y
Patent FI-912804-A0 (FI)
Inventor: HAENNINEN JOUNI
IPC: H04B17/00
Filed: 1991-06-11
Abstract: PCT No. PCT/FI92/00176 Sec. 371 Date Feb. 5, 1993 Sec. 102(e) Date Feb. 5, 1993 PCT Filed Jun. 5, 1992 PCT Pub. No. WO92/22963 PCT Pub. Date Dec. 23, 1992.The base station includes for monitoring the quality of a radio link between the base station and mobile stations, a generator (1, 2, 3) for generating a square wave signal (CK) having a monitoring signal frequency; and a filter (4) for generating a monitoring signal (CS) from the square wave signal (CK). The frequency of the monitoring signal is set by a control (12) having two modes of operation; in the first mode of operation, the control controls the generator to transmit an analog monitoring signal by maintaining the frequency of the square wave signal (CK) at a constant value throughout the duration of the monitored radio link, and in the second mode of operation, the control controls the generator (1, 2, 3) to transmit a digital monitoring signal by varying the frequency during the monitored radio link in response to changes in the logical state of the monitoring signal between a first frequency corresponding to the first logical state and a second frequency corresponding to the second logical state.
Patent FI-914414-A0 (FI)
Inventor: TANAKA HARUHIKO
IPC: C08L23/20
Filed: 1991-09-19
Abstract: 1. A polybutene-1 resin composition substantially comprising     (A) 60 to 95 weight parts of a polybutene-1 resin (A) having     (i) a melt flow rate of 0.01 to 5 g/10 min, (ii) the ratio (Mw/Mn) of weight average molecular weight (Mw) to number average molecular weight (Mn) of 6 or less, and   (iii) an isotactic value of 93 % or more, and     (B) 40 to 5 weight parts of a polybutene-1 resin (B) having   (i) a 20 times or more as large melt flow rate as that of the polybutene-1 resin (A), (ii) the ratio (Mw/Mn) of weight average molecular weight (Mw) to number average molecular weight (Mn)of 6 or less, and   (iii) an isotactic value of 93 % or more.   i
Patent FI-923394-A0 (FI)
Inventor: PECCEU HENDRIK
IPC: G05G1/00
Filed: 1992-07-27
Abstract: A mechanical shifting device has a casing (1) and a ball (5) fitted therein in a cage (4). On the input side a shifting lever (2) is arranged radially downwards on the ball (5) and rigidly secured which, together with the ball (5), can make two rotary movements about axes (19, 24) passing mutually perpendicular through the centre (6) of the ball (5). On the output side there are two separate transmission components (13, 23) which take the form of pins and are arranged with their axes parallel to each other. The two transmission components (13, 23) are each connected to the ball (5) via a freewheel, whereby the two freewheels are so constructed and mutually arranged that one freewheel has a conveyor function for one transmission component (13) on the first rotary movement of the shift lever (2) and the other has a freewheeling function for the other transmission component (23), while the situation is reversed in the second rotary movement of the shifting lever (2).
Patent FI-933660-A0 (FI)
Inventor: KALNY FRIEDRICH
IPC: H02M7/06
Filed: 1993-08-19
Abstract: Described is a power unit with a multi-phase supply for small consumers, in which phase circuits (L1, L2, L3) are connected through series impedances, in particular capacitors (C), to a d.c. supply point (SP) by means of diodes. A virtually constant load current is produced in single- or multi-phase operation by virtue of the fact that all the phase circuits (L2, L3) bar one last phase circuit (L1) are connected to each other and, at the connection point, connected through a common diode (D1) to the last phase circuit (L1).
Patent FI-942632-A0 (FI)
Inventor: NIST ROBERT LOUIS
IPC: C07D463/00
Filed: 1994-06-03
Abstract: Prodn. of the crystalline monohydrate form of loracarbef (I) comprises: (a) mixing a form of (I), other than the crystalline monohydrate form, in water at 30-60[deg]C; or (b) exposing a form of (I), other than the crystalline monohydrate form, to satd. steam at 90-100[deg]C.
Patent FI-953089-A0 (FI)
Inventor: DE NAUNEUIL GUILLAUME
IPC: C07K1/06
Filed: 1995-06-21
Abstract: Boronic acid peptide derivs. of formula (I) R1NH-C(R2)(R2')-CO-A-CO-NH-CH(R3)-B(OR4)(OR5) and their enantiomers, diastereomers and epimers and their addn. salts are new. In (I), R1 is e.g. H, 1-6C acyl, 2-7C alkoxycarbonyl, benzyloxycarbonyl, etc.; R2 is e.g. H, Ph, thienylmethyl, (pyridinyl) methyl, diphenylmethyl, fluoroenyl, naphthylmethyl etc.; R2' is H or benzyl; or R2+R2' is CHPh; R3 is e.g. (CH2)mSC(=NH)NHR, (CH2)mN(R)CH=NH or gp. of formula (a) etc.; m =1-6; R is H or 1-6C alkyl; X is S or amino; R4 and R5 are H or 1-6C alkyl; or B(OR4)(OR5) is pinanediol boronic ester; A is N(A2)(CH2)n; n = 1-2; A2 is e.g. Ph, indanyl, 3-7C cycloalkyl (opt. ring substd. by 1-6C alkyl), 3-7C cycloalkenyl, bicyclo(2.1.1)hexyl etc..
Patent FI-955268-A0 (FI)
Inventor: VAEISAENEN HANNU
IPC: H04W88/08
Filed: 1995-11-02
Abstract: PCT No. PCT/FI96/00580 Sec. 371 Date Jul. 1, 1997 Sec. 102(e) Date Jul. 1, 1997 PCT Filed Oct. 30, 1996 PCT Pub. No. WO97/16937 PCT Pub. Date May 9, 1997The invention relates to an interference-protected method and arrangement for supplying power, wherein the power supply between main devices and a masthead preamplifier of a base station in a cellular radio system takes place through an antenna line, and overvoltage formed on the antenna line is conducted to the ground by means of an overvoltage protector adapted for radio frequencies. The use of separate cables and separate overvoltage protector for the supply cable is thus avoided.
Patent FI-961169-A0 (FI)
Inventor: FU ROGER CHERNG
IPC: C07D413/12
Filed: 1996-03-13
Abstract: The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment.
Patent FI-961945-A0 (FI)
Inventor: BUONGIORNO LIVIO
IPC: B29C55/02
Filed: 1996-05-08
Abstract: A method of making the a multilayer, biaxially oriented, heat shrinkable thermoplastic film includes a layer having between 50 and 100 parts by weight ethylene/alpha-olefin C4-C12 copolymer, and between 0 and 50 parts by weight of a polymer selected from polyolefin, and modified polyolefin, the layer having more than one melting point when detected by diffential scanning calorimetry according to ASTM D-3418; wherein the total thickness variation in the multilayer film is lower than ±10%.
Patent FI-963152-A0 (FI)
Inventor: REITZ REINHOLD
IPC: F16B13/08
Filed: 1996-08-12
Abstract: For mounting the hollow ends (H) of a curved handle (G) in an orifice (B) on a contact face (A), a guide member (30) for a screw (29) has a base flange (31) which can be connected to a securing member (47) and on which there rests a tubular supporting member (12) which overlaps the hollow end (H). A cap nut (20) having a peripheral groove (24) for fixing the hollow end (H) by means of a setscrew V and having wrench faces (23) can be screwed onto a head (32) of the guide member (30). A door handle (50) reveiving a polygonal pin (47) can be fixed e.g. on a multi-chamber profile (M), the guide member (30) being secured externally by a flanged ring (55). <IMAGE>
Patent FI-964773-A0 (FI)
Inventor: LAUFER STEFAN
IPC: C07D498/04
Filed: 1996-11-29
Abstract: PCT No. PCT/EP95/02079 Sec. 371 Date Mar. 28, 1997 Sec. 102(e) Date Mar. 28, 1997 PCT Filed May 31, 1995 PCT Pub. No. WO95/32972 PCT Pub. Date Dec. 7, 1995The present invention relates to heterocyclic compounds of the formula in which R1-R7, B, a and X have the meanings recited in the specification. These compounds are usable in the treatment of diseases of the rheumatoid group and for the prevention of allergically induced diseases.
Patent FI-982204-A0 (FI)
Inventor: HUOPANIEMI JUHO
IPC: H04Q3/00
Filed: 1998-10-09
Abstract: System for establishing and controlling a telecommunication connection in a telecommunication network comprising a telecommunication terminal (1), a telephone exchange (2) and an intelligent network (3) comprising a service switching point (SSP), a gateway (GW), a signaling network (SS7) and one or more service control points (SCP). The service switching point (SSP) is connected to the gateway (GW) and the gateway is further connected to the signaling network (SS7). The service control points (SCP) are connected to the signaling network (SS7). In the method of the invention, the establishment and control of the telecommunication connection are managed by means of the intelligent network. The signaling associated with the telecommunication connection to be established is directed to a predetermined service control point (SCP-A) by setting the A-party number as the Global Title address of the signaling message.
Patent IL-59604-A0 (IL)
Title: Tripeptides and pharmaceutical compositions containing them
IPC: A61P37/04
Filed: 1980-03-13
Abstract: There are disclosed new biological active polypeptides:wherein A is deamino-LYS or LYS; X is a suitable neutral aliphatic amino acid residue; e.g., one selected from the group consisting of SER, ALA, 2-Me-ALA, GLY, LEU, THR, D-SER, D-ALA, D-THR, allo-THR, D-LEU, and SAR; B is GLN-R', decarboxy-GLN, orand R' is a substituent which does not substantially affect the biological activity of the tripeptide.These polypeptides have the capability of inducing the differentiation of T lymphocytes as measured by the acquisition of the thymic differentiation antigen Th-I, as well as B-lymphocytes as measured by the acquisition of the differentiation antigen Bu-i. The polypeptides are thus useful in thymic function and immunity areas such as in treatment for congenital absence of thymus. Also provided are therapeutic compositions and methods for use of the polypeptides.
Patent IL-75178-A0 (IL)
Title: 6-chlorobenzazolyloxyacetamides,their preparation and their use as herbicides and fungicides
IPC: C07D413/12
Filed: 1985-05-13
Abstract: Herbicidally and fungicidally active novel 6-chlorobenzazolyloxyacetanilides of the formula   <IMAGE>   in which R1 is alkyl with 1 to 6 carbon atoms, and R2 is phenyl which is optionally mono-, di- or tri-substituted by methyl or ethyl.
Patent IL-85084-A0 (IL)
Title: Pulverulent,water-dispersible carotenoid formulations and their preparation
IPC: A23K1/16
Filed: 1988-01-12
Abstract: Preparation of pulverulent water-dispersible carotenoid preparations in which the carotenoid is present dissolved in an edible oil and the oil solution is present in the form of small droplets, by rapidly dissolving a carotenoid in a volatile, water-miscible, organic solvent at between 50 and 240 DEG C together with from 1.5 to 20 times the weight, based on the carotenoid, of an edible oil and also an emulsifier, under atmospheric or superatmospheric pressure, immediately mixing the resulting molecularly dispersed solution with an aqueous solution of a protective colloid at between 0 DEG C and 50 DEG C to transfer the hydrophilic solvent component into the aqueous phase, forming the hydrophobic oil phase, which contains the carotenoid in solution, as a microdisperse phase, and stripping the resulting two-phase mixture of solvent and water in a conventional manner.
Patent IL-90207-A0 (IL)
Title: Biochemical oxidation of steroids and genetically engineered cells to be used therefor
IPC: C12N1/19
Filed: 1989-05-05
Abstract: Genetically engineered host cells containing new expression cassettes are provided which are able to carry out biochemical oxidations of steroids. In particular the oxidation is carried out with cells into which DNA has been introduced which encodes protein involved in the biological pathway of cholesterol to hydrocortisone. Suited host cells comprise species of $i(Bacillus), $i(Saccharomyces) or $i(Kluyveromyces). The new host cells are suited for microbiological oxidations of cholesterol, pregnenolone, progesterone, 17$g(a)-hydroxy-progesterone, and cortexolone, which are intermediates in said biological pathway. The new expression cassettes are also useful in the ultimate production of a multigenic system for a one-step conversion of cholesterol into hydrocortisone.
Patent IL-95843-A0 (IL)
Title: 1-hydroxy-1,2,4-triazole derivatives,their manufacture and their use as fungicides and growth regulators
IPC: C07D409/12
Filed: 1990-09-28
Abstract: Compounds of the formula I   <IMAGE> I  where Ar is unsubstituted or substituted phenyl, pyridyl, thienyl or napthyl, R1 is hydrogen or CN, R2 is unsubstituted or substituted aryl, hetaryl, alkyl or cycloalkyl, or is unsubstituted or substituted alkenyl or alkynyl, x is CH2, O or S and n is 0 or 1, their plant-tolerated acid addition salts and metal complexes, and fungicides and growth regulators containing these compounds.
Patent AU-PN817896-A0 (AU)
Title: Stormwater sediment and litter trap
IPC: E03F1/00
Filed: 1996-02-21
Abstract: A pollution control device (10) for removal of litter and sediments from a flowing stream of stormwater or the like, the device including an upwardly inclined flume (11,18) adapted to be disposed adjacent the discharge end of a stormwater outlet (16) with a collection container (12) at the opposite end of the flume, the flume (18) and the container (12) being fabricated from expanded metal mesh screen. During stormwater flow, litter entrained with the stormwater is urged up the inclined path of the flume (18) for collection in the container (12) whereas sediments are screened from the flume (18) and the container (12) through apertures in the expanded metal screen and pass through to a sediment sump (29) disposed beneath the device (10). Stormwater which has been so screened is then permitted to flow further downstream. A method of separating litter and sediments from a flowing stream of stormwater is also claimed.
Patent AU-PP971399-A0 (AU)
Title: Separation of plasma components
IPC: A61K38/00
Filed: 1999-04-12
Abstract: A method for separating components from plasma, the method comprising (I) separating the plasma into a first and second component, the first component comprising an albumin/alpha-1-antirypsin pool and the second component comprising plasma containing components having a molecular mass greater than albumin; (II) treating the second component to form an immunoglobulins concentrate containing immunoglobulins substantially free from components having a molecular mass less than immunoglobulins; (III) treating the immunoglobulins concentrate to remove components having a molecular mass greater than immunoglobulins; and (IV) separating albumin and alpha-1-antitrypsin from the albumin/alpha-1-antitrypsin pool.
Patent ES-511097-A0 (ES)
IPC: C07D209/36
Filed: 1982-04-02
Abstract: Oxindole derivatives of the general formula I    <IMAGE>  (I)  are described, and also processes for their preparation and drugs containing them. The new compounds exhibit a neuroanabolic action in various animal models.
Patent FI-20085862-A0 (FI)
Inventor: TYYBAEKINOJA JARNO
IPC: F41C/
Filed: 2008-09-12
Abstract: The invention relates to a holster for keeping a pistol. The holster includes a grip guard and locking mechanism for the pistol, as well as a lifting mechanism to raise the pistol out of the grip guard in the release situation. The locking mechanism includes a catch and its release device.
Patent IL-101180-A0 (IL)
Title: Indane derivatives,their preparation and their use as fragrance materials
IPC: C11D3/50
Filed: 1992-03-09
Abstract: The present invention relates to novel indane compounds of formula [I] <CHEM> (in which R<1>, R<2> and R<3> are defined in the specification), to compositions including them, to processes for their preparation, to novel intermediate compounds used in their preparation, and to their use as fragrance materials.
Patent IL-101758-A0 (IL)
Title: Controlled release matrix for pharmaceuticals
IPC: A61K9/52
Filed: 1992-05-01
Abstract: The controlled release of therapeutically active agents is achieved from a controlled release matrix of sodium alginate and a calcium salt. When the composition is to be administered rectally, the matrix is combined with a therapeutically active agent and a suitable suppository base. When the composition is to be administered orally, the matrix further includes a higher aliphatic alcohol.
Patent IL-103305-A0 (IL)
Title: Cardioprotective tocopherol analogs
IPC: A61K31/675
Filed: 1992-09-30
Abstract: This invention relates to alkylated phosphonium alkylene derivatives of certain 2H-1-benzopyrans, to the intermediates and processes useful for their preparation, to their free-radical scavenger and cardioprotective properties and to their end-use application as therapeutic agents.
Patent IL-108089-A0 (IL)
Title: Reactor for ozonization of water intended for human consumption
IPC: C02F1/50
Filed: 1993-12-20
Abstract: A reactor which includes three tanks in series, namely a first contact tank (1) which receives the water to be treated and intended for the direct and rapid oxidizing action by ozone which is introduced into the said tank and set in contact with the liquid (4) to be treated; a second contact tank (2) intended for disinfecting the liquid, into which tank the quantity of ozone is injected which is necessary for maintaining the residual ozone concentration necessary for disinfecting the water within the liquid to be treated; and a third contact tank (3) intended for providing the radical action of the ozone, into which tank, in addition to the ozone, a quantity of hydrogen peroxide is injected which is intended to increase the quantity of OH radicals available for reaction with the pollutants to be removed by oxidation, the treated water being removed from this third tank. <IMAGE>
Patent IL-108135-A0 (IL)
Title: Pharmaceutical compositions containing benzoisoxazoles
IPC: A61P25/28
Filed: 1993-12-22
Abstract: PCT No. PCT/GB93/02501 Sec. 371 Date Jul. 11, 1995 Sec. 102(e) Date Jul. 11, 1995 PCT Filed Dec. 7, 1993 PCT Pub. No. WO94/14816 PCT Pub. Date Jul. 7, 1994Compounds of formula (I)    <IMAGE>  (I)  in which X represents a group >O, >S, >C=O or >NR wherein R is hydrogen, C1-6 alkyl, phenyl or C7-12 phenalkyl, R1 and R2 each represent hydrogen or together represent an oxo group and R3, R4 and R5 each represent hydrogen or R1 represents hydrogen and two of R2, R3, R4 and R5 together represent the second bond of a double bond joining positions 7 and 8, 8 and 9 or 9 and 10 with the remaining two of R2, R3, R4 and R5 representing hydrogen, the compound optionally being in the form of a salt thereof formed with a physiologically acceptable inorganic or organic acid, are of value for the treatment of anxiety and in the improvement of learning ability and/or the reversal of amnesia.
Patent IL-110252-A0 (IL)
Title: Mos device
IPC: H01L21/20
Filed: 1994-07-08
Abstract: A high-frequency wireless communication system on a single ultrathin silicon on sapphire chip is presented. This system incorporates analog, digital (logic and memory) and high radio frequency circuits on a single ultrathin silicon on sapphire chip. The devices are fabricated using conventional bulk silicon CMOS processing techniques. Advantages include single chip architecture, superior high frequency performance, low power consumption and cost effective fabrication.